Author

A.-C. Prats

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:mouse· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Approach:biophysical modeling· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

B. Garmy-Susini· 2 shared E. Lacazette· 2 shared E. Renaud-Gabardos· 2 shared F. Pujol· 2 shared A. Bura-Riviere· 1 shared A. Henras· 1 shared A. Lamaa· 1 shared A. Parini· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

B. Garmy-Susini

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema

A. Lamaa, J. Creff, E. Benuzzi, F. Pujol, T. Draia-Nicolau, M. Nougue, L. Verdu, F. Morfoisse, E. Lacazette, P. Valet, B. Chaput, F. Gross, R. Gayon, P. Bouille, J. Malloizel-Delaunay, , B. Garmy-Susini

This study identifies apelin as a therapeutic molecule for secondary lymphedema, showing it enhances lymphatic function through VEGF-C and pathways involving Akt and eNOS, with a novel RNA delivery system for clinical evaluation.

bioRxiv · Jan 5, 2023 · PreprintPathology

Ephrin-B1 blocks adult cardiomyocyte proliferation and heart regeneration

M. Cauquil, C. Mias, C. Guilbeau-Frugier, C. Karsenty, M.-H. Seguelas, G. Genet, E. Renaud-Gabardos, A.-C. Prats, V. Pons, M. Branchereau, C. Heymes, D. Calise, O. Lairez, D. Daviaud, B. Honton, , C. Gales

This study identifies ephrin-B1 as a regulator of adult cardiomyocyte proliferation and heart regeneration, showing its role in blocking proliferation and its potential as a therapeutic target.

bioRxiv · Aug 15, 2019 · PreprintPhysiology

Vasohibin1, a new IRES trans-acting factor for induction of (lymph)angiogenic factors in early hypoxia

F. Hantelys, A.-C. Godet, F. David, F. Tatin, E. Renaud-Gabardos, F. Pujol, L. Diallo, I. Ader, L. Ligat, A. Henras, Y. Sato, E. Lacazette, A. Parini, B. Garmy-Susini, A.-C. Prats

The paper identifies vasohibin1 as an IRES trans-acting factor that activates angiogenic IRESs in early hypoxia while inhibiting others in normoxia.

bioRxiv · Jul 11, 2019 · PreprintCell Biology